Annual Accounts Payable
$1.84 M
+$35.10 K+1.94%
30 September 2022
Summary:
NeuBase Therapeutics annual accounts payable is currently $1.84 million, with the most recent change of +$35.10 thousand (+1.94%) on 30 September 2022. During the last 3 years, it has risen by +$35.10 thousand (+1.94%).NBSE Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Payable
$258.60 K
-$63.50 K-19.71%
30 September 2023
Summary:
NeuBase Therapeutics quarterly accounts payable is currently $258.60 thousand, with the most recent change of -$63.50 thousand (-19.71%) on 30 September 2023.NBSE Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NBSE Accounts Payable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | +1.9% | -85.7% |
| 5 y5 years | +24.8% | -82.5% |
NBSE Accounts Payable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | ||||
| 5 y | 5 years | ||||
| alltime | all time | at high | -96.1% |
NeuBase Therapeutics Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2023 | - | $258.60 K(-19.7%) |
| June 2023 | - | $322.10 K(-45.4%) |
| Mar 2023 | - | $590.20 K(+59.7%) |
| Dec 2022 | - | $369.50 K(-80.0%) |
| Sept 2022 | $1.84 M(+1.9%) | $1.84 M(+11.3%) |
| June 2022 | - | $1.66 M(+2.1%) |
| Mar 2022 | - | $1.62 M(+35.8%) |
| Dec 2021 | - | $1.19 M(-34.0%) |
| Sept 2021 | $1.81 M(+20.1%) | $1.81 M(+19.0%) |
| June 2021 | - | $1.52 M(-30.2%) |
| Mar 2021 | - | $2.18 M(+84.7%) |
| Dec 2020 | - | $1.18 M(-21.7%) |
| Sept 2020 | $1.50 M | $1.50 M(+14.8%) |
| June 2020 | - | $1.31 M(-21.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2020 | - | $1.66 M(+21.8%) |
| Dec 2019 | - | $1.37 M(-7.5%) |
| Sept 2019 | $1.48 M(+6707.4%) | $1.48 M(+6707.4%) |
| Sept 2018 | $21.70 K(-61.0%) | $21.70 K(-98.2%) |
| Dec 2014 | - | $1.19 M(-82.1%) |
| June 2014 | - | $6.66 M(+3989.4%) |
| Mar 2010 | - | $162.80 K(+153.2%) |
| Dec 2009 | - | $64.30 K(+21.3%) |
| June 2009 | - | $53.00 K(0.0%) |
| Mar 2009 | - | $53.00 K(0.0%) |
| Dec 2008 | - | $53.00 K(-4.7%) |
| Sept 2008 | $55.60 K(-76.8%) | $55.60 K(+42.6%) |
| June 2008 | - | $39.00 K(-75.5%) |
| Mar 2008 | - | $159.00 K(-33.8%) |
| Sept 2007 | $240.00 K | $240.00 K |
FAQ
- What is NeuBase Therapeutics annual accounts payable?
- What is the all time high annual accounts payable for NeuBase Therapeutics?
- What is NeuBase Therapeutics quarterly accounts payable?
- What is the all time high quarterly accounts payable for NeuBase Therapeutics?
What is NeuBase Therapeutics annual accounts payable?
The current annual accounts payable of NBSE is $1.84 M
What is the all time high annual accounts payable for NeuBase Therapeutics?
NeuBase Therapeutics all-time high annual accounts payable is $1.84 M
What is NeuBase Therapeutics quarterly accounts payable?
The current quarterly accounts payable of NBSE is $258.60 K
What is the all time high quarterly accounts payable for NeuBase Therapeutics?
NeuBase Therapeutics all-time high quarterly accounts payable is $6.66 M